Accurate Preoperative Evaluation of the Location of Esophagogastric Junction Adenocarcinoma Using Positron Emission Tomography-Computed Tomography.

BACKGROUND The surgical procedure for esophagogastric junction (EGJ) adenocarcinoma usually depends on the location of its epicenter or proximal margin, but accurate evaluation of these positions is often difficult. The usefulness of positron emission tomography-computed tomography (PET-CT) for this purpose is unknown. METHODS Between June 2005 and February 2015, we enrolled 30 patients with cT2-4 EGJ adenocarcinoma (Siewert type I/II) who underwent surgical resection. We ascertained the sensitivity and specificity of preoperative PET-CT for identifying the primary tumor and regional lymph node metastasis, and compared PET-CT and pathological findings in terms of the distance from the EGJ to the tumor epicenter or proximal tumor margin. RESULTS PET-CT detected the primary tumor with a sensitivity of 97% (29/30), and detected lymph node metastasis with a sensitivity and specificity of 22% (4/18) and 100% (8/8), respectively. No significant association was observed between the maximal standardized uptake value and histological type, tumor size, or pT status. Regarding the accuracy of evaluating tumor location, the median differences between PET-CT and pathological measurements were .6 cm for the tumor epicenter and .5 cm for the proximal margin from the EGJ. PET-CT and pathological findings showed agreement regarding Siewert classification type (I or II) and lengths of esophageal involvement exceeding 4 cm or 2 cm in 77% (10/13), 85% (11/13), and 85% (11/13) of cases, respectively. DISCUSSION PET-CT had high sensitivity for primary EGJ adenocarcinoma. It may effectively locate the tumor epicenter and proximal margin and thus help clinicians determine the optimal surgical procedure.

[1]  Y. Doki,et al.  Surgical Treatment of Gastroesophageal Junction Cancer , 2018, Journal of gastric cancer.

[2]  Y. Seto,et al.  Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma , 2017, Gastric Cancer.

[3]  Y. Doki,et al.  Impact of number of [18F]fluorodeoxyglucose‐PET‐positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer , 2015, The British journal of surgery.

[4]  T. Yoshikawa,et al.  Ten‐year follow‐up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia , 2015, The British journal of surgery.

[5]  W. Schreurs,et al.  PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  E. Hindié,et al.  Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  J. Hatazawa,et al.  The Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography Positive Lymph Nodes on Postoperative Recurrence and Survival in Resectable Thoracic Esophageal Squamous Cell Carcinoma , 2012, Annals of Surgical Oncology.

[8]  H. Shimada,et al.  Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature , 2011, Gastric Cancer.

[9]  B. Krause,et al.  New trends for staging and therapy for localized gastroesophageal cancer: the role of PET. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  Z. Keidar,et al.  Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis , 2010, Journal of Nuclear Medicine.

[11]  Michael A. Blake,et al.  Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements. , 2009, Academic radiology.

[12]  N. Holalkere,et al.  Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  A. Fischman,et al.  Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. , 2008, The Annals of thoracic surgery.

[14]  Soo Young Kim,et al.  Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. , 2007, European journal of cancer.

[15]  J. Siewert,et al.  The importance of PET in the diagnosis and response evaluation of esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[16]  David Binns,et al.  A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  K. Kang,et al.  Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Y. Doki,et al.  Mucin phenotypic expression and background mucosa of esophagogastric junctional adenocarcinoma , 2004, Gastric Cancer.

[19]  T. Sugino,et al.  Expression of glucose transporter‐1 in human gastric carcinoma , 2001, Cancer.

[20]  H. Stein,et al.  Classification of adenocarcinoma of the oesophagogastric junction , 1998, The British journal of surgery.

[21]  J. Wong,et al.  Shrinkage of the Esophagus after Resection for Carcinoma , 1986, Annals of surgery.

[22]  PhD Facs Hideo Baba MD,et al.  Outcomes of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Esophagectomy in Patients with Resectable Node-Positive Esophageal Cancer , 2014, Annals of Surgical Oncology.

[23]  Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.

[24]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.